Although the active form of heparanase has been identified as a key player in multiple myeloma (52) and sarcoma (77), several other studies have linked the overexpression of the active form with aggressive primary tumor growth, invasion, and metastasis in certain cancer types. Here, HPSE is linked to plasma cell myeloma.